Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Revenue (2016 - 2025)

Wave Life Sciences' Revenue history spans 11 years, with the latest figure at $8.7 million for Q2 2025.

  • For Q2 2025, Revenue fell 55.82% year-over-year to $8.7 million; the TTM value through Dec 2025 reached $17.9 million, down 92.29%, while the annual FY2025 figure was $42.7 million, 60.55% down from the prior year.
  • Revenue reached $8.7 million in Q2 2025 per WVE's latest filing, down from $9.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $199.5 million in Q4 2024 to a low of $285000.0 in Q3 2022.
  • Average Revenue over 5 years is $41.4 million, with a median of $16.3 million recorded in 2023.
  • Peak YoY movement for Revenue: crashed 99.22% in 2022, then soared 17168.07% in 2023.
  • A 5-year view of Revenue shows it stood at $77.9 million in 2021, then grew by 4.24% to $81.2 million in 2022, then soared by 57.88% to $128.2 million in 2023, then skyrocketed by 55.62% to $199.5 million in 2024, then tumbled by 95.64% to $8.7 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Revenue are $8.7 million (Q2 2025), $9.2 million (Q1 2025), and $199.5 million (Q4 2024).